<DOC>
	<DOCNO>NCT00123656</DOCNO>
	<brief_summary>Eosinophilic esophagitis ( EE ) recently recognize entity . It think related allergy acid reflux . There report swallow , aerosolized steroid proton pump inhibitor effective treatment . The researcher propose directly compare efficacy aerosolize fluticasone esomeprazole treatment eosinophilic esophagitis . The hypothesis aerosolize fluticasone ( Flovent ) effective relieving symptom EE esomeprazole ( Nexium ) treatment . Patients undergo endoscopy , pH monitoring manometry diagnosis . Following diagnosis EE pathology ( biopsy esophagus ) , patient randomize esomeprazole swallow fluticasone 8 week . At end 8 week , subject ask repeat upper endoscopy biopsy . Three questionnaire ( dysphagia , gastroesophageal reflux disease [ GERD ] , allergy ) complete patient first endoscopy end endoscopy . The primary objective measure change eosinophil infiltration esophagus response treatment allergy ( swallow fluticasone ) versus treatment reflux ( esomeprazole ) EE patient .</brief_summary>
	<brief_title>Comparison Esomeprazole Aerosolized , Swallowed Fluticasone Eosinophilic Esophagitis</brief_title>
	<detailed_description>This randomize , non-blinded , multicenter treatment trial demonstrate compare efficacy esomeprazole fluticasone treatment eosinophilic esophagitis . Following initial diagnostic EGD four quadrant biopsy , serum eosinophil count serum IgE level measure . Patients undergo 24 hour pH study determine incidence reflux population . Clinical assessment perform validated questionnaire quantify dysphagia , GERD , allergy/atopy . Patients randomize 8 week either esomeprazole versus swallow aerosolized fluticasone . After 8 week therapy , upper endoscopy perform . Eosinophils per high power field quantify , biopsy stain major basic protein . Dysphagia , GERD , allergy/atopy questionnaire repeat , serum eosinophil count IgE measurement .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Patients age 1880 EE , define : ) dysphagia , food impaction upper gastrointestinal symptom ( chest pain , heartburn , regurgitation ) ; b ) multiple esophageal ring furrow ; c ) presence &gt; 20 eosinophils/high power field squamous epithelium deeper tissue esophagus Ability undergo esophageal manometry ambulatory pH monitor No history bleed diathesis , significant cardiopulmonary disease , contraindication upper endoscopy Those one month holiday either esomeprazole therapy fluticasone prescribe prior enrollment Contraindication proton pump inhibitor swallow fluticasone Need immediate esophageal dilation enrollment due food impaction discretion perform endoscopist Inability pas endoscope Pregnancy Incarceration Inability provide informed consent History esophagogastric surgery prior history abdominal surgery subsequent strictures symptom obstruction abdominal pain bloat Presence esophageal pathology could account patient ' symptom determine histological interpretation pathologist History esophageal spasm result trouble swallow food large 1 cm diameter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Eosinophilic esophagitis</keyword>
	<keyword>esomeprazole</keyword>
	<keyword>fluticasone</keyword>
</DOC>